Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Farber

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Postgraduate Medicine|August 1, 1990
Macular degeneration. A devastating but treatable diseaseM E Farber, A S Farber
The New England Journal of Medicine|April 12, 1979
A cost-benefit analysis of a mandatory premarital rubella-antibody screening programM E Farber, S N Finkelstein
The West Virginia Medical Journal|April 1, 1989
Diabetic retinopathy in a rural diabetic population. Prevalence and riskW H Benson, M E Farber
Medical Care|October 1, 1976
Nursing homes and the Roemer-Feldstein hypothesisT R Willemain, M E Farber
The New England Journal of Medicine|July 26, 1979
Cost-benefit analysis of rubella screeningM E Farber, S N Finkelstein
Clinical Chemistry|June 1, 1980
Urinary oxalate indirectly determined by continuous-flow analysis for calciumR H Sample, M E Farber, M R Glick
Ophthalmology|September 1, 1988
Increased mortality rates after cataract surgery. A statistical analysisW H Benson, M E Farber, R J Caplan
Ophthalmology|February 1, 1989
Increased retinal vascular tortuosity in gestational diabetes mellitusM I Boone, M E Farber, L Jovanovic-Peterson, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 1, 1986
Test accuracy and predicting outcomeJ V Odom, G W Weinstein, M E Farber, et al.
Ophthalmology|May 1, 1985
Perfluorocarbon gases in vitreous surgeryS Chang, H A Lincoff, D J Coleman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Postgraduate Medicine|August 1, 1990
Macular degeneration. A devastating but treatable diseaseM E Farber, A S Farber
The New England Journal of Medicine|April 12, 1979
A cost-benefit analysis of a mandatory premarital rubella-antibody screening programM E Farber, S N Finkelstein
The West Virginia Medical Journal|April 1, 1989
Diabetic retinopathy in a rural diabetic population. Prevalence and riskW H Benson, M E Farber
Medical Care|October 1, 1976
Nursing homes and the Roemer-Feldstein hypothesisT R Willemain, M E Farber
The New England Journal of Medicine|July 26, 1979
Cost-benefit analysis of rubella screeningM E Farber, S N Finkelstein
Clinical Chemistry|June 1, 1980
Urinary oxalate indirectly determined by continuous-flow analysis for calciumR H Sample, M E Farber, M R Glick
Ophthalmology|September 1, 1988
Increased mortality rates after cataract surgery. A statistical analysisW H Benson, M E Farber, R J Caplan
Ophthalmology|February 1, 1989
Increased retinal vascular tortuosity in gestational diabetes mellitusM I Boone, M E Farber, L Jovanovic-Peterson, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 1, 1986
Test accuracy and predicting outcomeJ V Odom, G W Weinstein, M E Farber, et al.
Ophthalmology|May 1, 1985
Perfluorocarbon gases in vitreous surgeryS Chang, H A Lincoff, D J Coleman, et al.
Pageof 1